Baxter Review

USD/CAD Drifts to Three-Session Low Under 1.2100

USD/CAD has drifted to a three-session low under 1.2100, returning focus to Friday’s 28-month low at 1.2062. Action Economics said that they continue to recommend...
Rockwell Medical Says Richmond Group-Backed Director Mark Ravich “Failed to Attend” Board Meet

Rockwell Medical (RMTI) said in response to the filing by Richmond Group of an amended Schedule 13D with the SEC Monday it has been “attempting...
Moleculin Biotech to Meet With EMA

Moleculin Biotech said Tuesday it will meet with the European Medicines Agency (EMA) Aug. 30 to discuss clinical trial authorization for the study of annamycin...
Spectrum Pharmaceuticals Starts Phase 3 Trial

Spectrum Pharmaceuticals a developer of hematology and oncology treatments, said Monday it has enrolled the first patient in a phase 3 trial of Qapzola, a...
Cambrex Q2 Earnings Meet Views as Revenues Miss

Cambrex reported Friday mixed results for Q2 while increasing its adjusted earnings per share guidance for the year. Q2 adjusted EPS was $0.76, up from...

Recent Stock Central

USD/CAD Drifts to Three-Session Low Under 1.2100 By Kevin Lester | September 12, 2017

Rockwell Medical Says Richmond Group-Backed Director Mark Ravich “Failed to Attend” Board Meet By Shane Howell | August 30, 2017

Moleculin Biotech to Meet With EMA By Shane Howell | August 22, 2017

Spectrum Pharmaceuticals Starts Phase 3 Trial By Mary Jones | August 14, 2017

Cambrex Q2 Earnings Meet Views as Revenues Miss By Lucy Watters | August 04, 2017

View All Recent Stock Central ≫